Abramson, J. S., Ku, M., Hertzberg, M., Fox, C. P., Herbaux, C., Yoon, D. H., Kim, W. S., Zhang, H., Abdulhaq, H., Townsend, W., Mulvihill, E., Orellana-Noia, V., Ta, R., Huang, H., Kallemeijn, M., Belousov, A., Bottos, A., Lundberg, L., Gregory, G. P. (2025). Glofitamab plus gemcitabine and oxaliplatin (Glofit-GemOx) in patients (pts) with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL): 2-year (yr) follow-up of STARGLO.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.7015